Cargando…

Vascular Disease and Risk Stratification for Ischemic Stroke and All-Cause Death in Heart Failure Patients without Diagnosed Atrial Fibrillation: A Nationwide Cohort Study

BACKGROUND: Stroke and mortality risk among heart failure patients previously diagnosed with different manifestations of vascular disease is poorly described. We conducted an observational study to evaluate the stroke and mortality risk among heart failure patients without diagnosed atrial fibrillat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melgaard, Line, Gorst-Rasmussen, Anders, Rasmussen, Lars Hvilsted, Lip, Gregory Y. H., Larsen, Torben Bjerregaard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807813/ https://www.ncbi.nlm.nih.gov/pubmed/27015524 http://dx.doi.org/10.1371/journal.pone.0152269

Ejemplares similares

Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
por: Rasmussen, Lars Hvilsted, et al.
Publicado: (2012)

Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study
por: Nielsen, Peter Brønnum, et al.
Publicado: (2022)

Seasonality, incidence and prognosis in atrial fibrillation and stroke in Denmark and New Zealand
por: Christensen, Anette Luther, et al.
Publicado: (2012)

Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis
por: Melgaard, Line, et al.
Publicado: (2021)

Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study
por: Lip, Gregory Y H, et al.
Publicado: (2012)

Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes
por: Larsen, Torben Bjerregaard, et al.
Publicado: (2014)

Risk of stroke and bleeding in patients with heart failure and chronic kidney disease: a nationwide cohort study
por: Melgaard, Line, et al.
Publicado: (2018)

Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study
por: Nielsen, Peter Brønnum, et al.
Publicado: (2016)

Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study
por: Højen, Anette Arbjerg, et al.
Publicado: (2022)

Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
por: Larsen, Torben Bjerregaard, et al.
Publicado: (2016)

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
por: Nielsen, Peter Brønnum, et al.
Publicado: (2017)

Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity‐Weighted Cohort Study
por: Søgaard, Mette, et al.
Publicado: (2019)

Pre-existing atrial fibrillation and risk of arterial thromboembolism and death following pneumonia: a population-based cohort study
por: Gamst, Jacob, et al.
Publicado: (2014)

Bleeding Complications in Anticoagulated Patients With Atrial Fibrillation and Sepsis: A Propensity‐Weighted Cohort Study
por: Søgaard, Mette, et al.
Publicado: (2017)

Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer
por: Ording, Anne Gulbech, et al.
Publicado: (2022)

Pre-existing atrial fibrillation and risk of arterial thromboembolism and death in intensive care unit patients: a population-based cohort study
por: Gamst, Jacob, et al.
Publicado: (2015)

Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes
por: Boriani, Giuseppe, et al.
Publicado: (2016)

Psychotropic drug use following venous thromboembolism versus diabetes mellitus in adolescence or young adulthood: a Danish nationwide cohort study
por: Højen, Anette Arbjerg, et al.
Publicado: (2019)

Corrigendum: Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes
por: Boriani, Giuseppe, et al.
Publicado: (2017)

Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants
por: Ording, Anne Gulbech, et al.
Publicado: (2021)

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
por: Nielsen, Peter Brønnum, et al.
Publicado: (2019)

Atrial fibrillation in patients with severe mental disorders and the risk of stroke, fatal thromboembolic events and bleeding: a nationwide cohort study
por: Søgaard, Mette, et al.
Publicado: (2017)

Risk of stroke or systemic embolism in patients with degenerative mitral stenosis with or without atrial fibrillation: A cohort study
por: Steiner, Daniel Kjærgaard, et al.
Publicado: (2022)

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
por: Olesen, Jonas Bjerring, et al.
Publicado: (2011)

Stroke and bleeding risk stratification in atrial fibrillation: a critical appraisal
por: Lane, Deirdre A, et al.
Publicado: (2020)

Newly diagnosed atrial fibrillation and hospital utilization in heart failure: a nationwide cohort study
por: Vinter, Nicklas, et al.
Publicado: (2021)

Exercise and the Risk of Dementia in Patients with Newly Diagnosed Atrial Fibrillation: A Nationwide Population-Based Study
por: Lim, Jaehyun, et al.
Publicado: (2021)

Management of Cancer-Associated Venous Thrombosis: A Nationwide Survey among Danish Oncologists
por: Højen, Anette Arbjerg, et al.
Publicado: (2021)

Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care
por: Lane, Deirdre A., et al.
Publicado: (2017)

Risk of New-Diagnosed Atrial Fibrillation After Transient Ischemic Attack
por: Purroy, Francisco, et al.
Publicado: (2022)

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation
por: Grove, Erik Lerkevang, et al.
Publicado: (2018)

The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis
por: Vestergaard, Anne Sig, et al.
Publicado: (2017)

Risk of myocardial infarction and ischemic stroke in individuals with first-diagnosed paroxysmal vs. non-paroxysmal atrial fibrillation under anticoagulation
por: Ntaios, George, et al.
Publicado: (2023)

Continuous Glucose Monitoring Sensor Glucose Levels and Insulin Pump Infusion Set Wear-Time During Treatment with Fast-Acting Insulin Aspart: A Post Hoc Analysis of Onset 5
por: Gorst-Rasmussen, Anders, et al.
Publicado: (2022)

Targeted Atrial Fibrillation Therapy and Risk Stratification Using Atrial Alternans
por: Muthavarapu, Neha, et al.
Publicado: (2023)

Diabetes and atrial fibrillation: stratification and prevention of stroke risks
por: v Bandemer, Stephan, et al.
Publicado: (2014)

Qualitative factors shaping MS patients’ experiences of infusible disease-modifying drugs: a critical incident technique analysis
por: Larsen, Janni Lisander, et al.
Publicado: (2020)

The complexity of atrial fibrillation newly diagnosed after ischemic stroke and transient ischemic attack: advances and uncertainties
por: Cerasuolo, Joshua O., et al.
Publicado: (2017)

Lower atrial fibrillation recurrence after ablation in general anesthesia - a danish nationwide registry study
por: Riis-Vestergaard, L, et al.
Publicado: (2023)

P‐wave indices as predictors of atrial fibrillation
por: Rasmussen, Maria Uggen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vq6i522tolcoof3icdp7botvbm